Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities.

[1]  Cardiac and pulmonary norepinephrine release and removal in the dog. , 1983, Circulation research.

[2]  H. Saito,et al.  Plasma Norepinephrine Concentration and Plasma Dopamine–beta–hydroxylase Activity in Patients with Congestive Heart Failure , 1983, Circulation.

[3]  J. Cohn,et al.  Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. , 1982, American heart journal.

[4]  J. Keul,et al.  Correlations of hemodynamic parameters with plasma catecholamines in patients with congestive cardiomyopathy , 1982, Clinical cardiology.

[5]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[6]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[7]  D. Jacobowitz,et al.  Increased dopamine in the failing hamster heart: transvesicular transport of dopamine limits the rate of norepinephrine synthesis. , 1982, The American journal of cardiology.

[8]  J. Cohn,et al.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.

[9]  P. Cryer.  Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. , 1980, The New England journal of medicine.

[10]  H. Saimyoji,et al.  Role of endocrine factors in chronic congestive heart failure, with emphasis on catecholamines. , 1980, Japanese circulation journal.

[11]  K. Swedberg,et al.  Effects of work and acute beta‐receptor blockade on myocardial noradrenaline release in congestive cardiomyopathy , 1979, Clinical cardiology.

[12]  W. Nayler,et al.  Uptake of catecholamines by human cardiac muscle in vitro. , 1979, British heart journal.

[13]  T. Slotkin,et al.  SYNAPTIC VESICLES ISOLATED FROM RAT HEART: l‐[3H]NOREPINEPHRINE UPTAKE PROPERTIES 1 , 1979, Journal of neurochemistry.

[14]  N. Christensen,et al.  Determinants of coronary sinus noradrenaline in patients with ischaemic heart disease: coronary sinus catecholamine concentration in relation to arterial catecholamine concentration, pulmonary artery oxygen saturation and left ventricular end-diastolic pressure. , 1978, Cardiovascular research.

[15]  I. Kopin,et al.  Plasma levels of norepinephrine. , 1978, Annals of internal medicine.

[16]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[17]  Bevan Ja.  Some functional consequences of variation in adrenergic synaptic cleft width and in nerve density and distribution. , 1977 .

[18]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[19]  R. Wurtman,et al.  Tyrosine hydroxylase activity in the heart of the cardiomyopathic syrian hamster. , 1977, Journal of molecular and cellular cardiology.

[20]  I. Kopin,et al.  Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. , 1976, Life sciences.

[21]  R. Nadeau,et al.  Correlation between the Response of the Heart to Sympathetic Stimulation and the Release of Endogenous Catecholamines into the Coronary Sinus of the Dog , 1975, Circulation research.

[22]  G. Diamond,et al.  Thermodilution cardiac output determination with a single flow-directed catheter. , 1972, American heart journal.

[23]  E. Braunwald,et al.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.

[24]  E. Braunwald,et al.  CARDIAC NOREPHINEPHRINE STORES IN EXPERIMENTAL HEART FAILURE IN THE DOG. , 1964, The Journal of clinical investigation.